Related Experiment Video
Updated: Jul 29, 2026

Universal Screening for Prevention of Reading, Writing, and Math Disabilities in Spanish
Published on: July 18, 2020
CCHD Screening Implementation Efforts in Latin American Countries by the Ibero American Society of Neonatology
Augusto Sola1, Susana Rodríguez1, Alejandro Young1
1Neonatology, Ibero-American Society of Neonatology (SIBEN), Wellington, FL 33414, USA; susana.rodriguez@siben.net (S.R.); alejandro.young@siben.net (A.Y.); lourdes.lemus@siben.net (L.L.V.); ramon.mir@siben.net (R.M.V.); marcelo.cardetti@siben.net (M.C.); jpleitez@gmail.com (J.P.N.); veronicafavareto@hotmail.com (M.V.F.); limamv@hotmail.com (V.L.); hbaquero@uninorte.edu.co (H.B.); lorenavforero@gmail.com (L.V.F.); davilacarmen@hotmail.com (C.D.); fddieppa@infomed.sld.cu (F.D.D.); tainamalenag@yahoo.com (T.M.G.); ada2552@ice.co.cr (A.N.O.B.); alacfe@yahoo.es (A.L.A.C.); monica.morgues@siben.net (M.M.); aldasolav@yahoo.com.ar (A.A.); diana.farina@siben.net (D.F.); joseloliva@hotmail.com (J.L.O.); sergio.golombek@siben.net (S.G.).
Insights
Pulse oximetry screening (POS) helps detect critical congenital heart disease (CHD) in newborns. Despite challenges in Latin America, POS implementation is vital for reducing infant mortality and saving lives.
Area of Science:
- Neonatology
- Public Health
- Pediatric Cardiology
Background:
- Congenital heart disease (CHD) is a leading cause of infant mortality in Latin America.
- Early diagnosis of critical CHD is crucial for improved neonatal outcomes.
- Pulse oximetry screening (POS) is an effective tool for early detection.
Purpose of the Study:
- To describe the implementation of POS in Latin American countries.
- To identify challenges faced in achieving universal POS implementation.
- To highlight the role of the Ibero American Society of Neonatology (SIBEN) in these efforts.
Main Methods:
- Coordination and guidance by SIBEN across 12 Latin American countries.
- Education of neonatal nurses and neonatologists on POS protocols.
- Assessment of progress and challenges in POS implementation.
Main Results:
- Significant progress has been made in POS implementation despite existing disparities in care.
- Challenges in implementation vary widely between and within countries.
- POS has proven valuable for diagnosing CHD and other hypoxemic conditions.
Conclusions:
- Universal POS implementation in Latin America is challenging but achievable.
- Successful POS execution significantly benefits newborns with CHD and other conditions.
- Widespread POS adoption is essential for reducing infant mortality and improving survival rates.
Abstract:
Congenital heart disease (CHD) is among the four most common causes of infant mortality in Latin America. Pulse oximetry screening (POS) is useful for early diagnosis and improved outcomes of critical CHD. Here, we describe POS implementation efforts in Latin American countries guided and/or coordinated by the Ibero American Society of Neonatology (SIBEN), as well as the unique challenges that are faced for universal implementation. SIBEN collaborates to improve the neonatal quality of care and outcomes. A few years ago, a Clinical Consensus on POS was finalized. Since then, we have participated in 12 Latin American countries to educate neonatal nurses and neonatologists on POS and to help with its implementation. The findings reveal that despite wide disparities in care that exist between and within countries, and the difficulties and challenges in implementing POS, significant progress has been made. We conclude that universal POS is not easy to implement in Latin America but, when executed, has not only been of significant value for babies with CHD, but also for many with other hypoxemic conditions. The successful and universal implementation of POS in the future is essential for reducing the mortality associated with CHD and other hypoxemic conditions and will ultimately lead to the survival of many more Latin American babies. POS saves newborns' lives in Latin America.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Cardiomyopathy III: Hypertrophic Cardiomyopathy
American Trypanosomiasis

